Athira Pharma ATHA

$ 0.54 -1.05%

Quarterly report 2024-Q3
added 11-07-2024

Athira Pharma Balance Sheet 2011-2024 | ATHA

Annual Balance Sheet Athira Pharma

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-89 M	-94.1 M	-109 M	-60.6 M	-503 K	-2.6 M	-	-	-	-	-	-	-
Long Term Debt	1.22 M	1.58 M	1.63 M	-	1.55 M	722 K	-	-	-	-	-	-	-
Long Term Debt Current	368 K	326 K	288 K	124 K	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	876 K	20.6 M	19.2 M	-	-	-	-	-	-	-
Total Current Liabilities	28.8 M	21.4 M	9.29 M	4.4 M	-	-	-	-	-	-	-	-	-
Total Liabilities	30.1 M	23 M	10.9 M	5.28 M	21.9 M	19.8 M	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-309 M	-192 M	-95.9 M	-	-21.1 M	-15.9 M	-	-	-	-	-	-	-
Total Assets	160 M	258 M	332 M	280 M	2.19 M	4.93 M	-	-	-	-	-	-	-
Cash and Cash Equivalents	90.6 M	96 M	111 M	60.6 M	-	-	-	-	-	-	-	-	-
Book Value	130 M	235 M	321 M	274 M	-19.7 M	-14.9 M	-	-	-	-	-	-	-
Total Shareholders Equity	130 M	235 M	321 M	274 M	-19.7 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Athira Pharma

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	912 K	1.02 M	1.12 M	1.22 M	1.31 M	1.41 M	1.5 M	1.58 M	1.67 M	1.75 M	1.55 M	1.63 M	1.71 M	1.78 M	1.7 M	876 K	876 K	876 K	876 K	1.55 M	1.55 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	28.7 M	27.9 M	26.7 M	30.1 M	29.9 M	23.1 M	21.6 M	23 M	11.9 M	11.4 M	11 M	10.9 M	11.1 M	9.42 M	6.2 M	5.28 M	5.28 M	5.28 M	5.28 M	4.86 M	4.86 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-391 M	-362 M	-336 M	-309 M	-282 M	-249 M	-219 M	-192 M	-161 M	-141 M	-117 M	-95.9 M	-79.6 M	-63.9 M	-49.9 M	-41 M	-41 M	-41 M	-41 M	-21.1 M	-21.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	86.2 M	111 M	133 M	160 M	185 M	208 M	233 M	258 M	274 M	292 M	313 M	332 M	347 M	360 M	369 M	280 M	280 M	280 M	280 M	2.19 M	2.19 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	68.9 M	73.8 M	77.8 M	90.6 M	110 M	114 M	105 M	96 M	87 M	95.1 M	118 M	111 M	107 M	132 M	128 M	60.6 M	60.6 M	60.6 M	60.6 M	2.06 M	2.06 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	57.6 M	83.3 M	107 M	130 M	155 M	185 M	211 M	235 M	262 M	281 M	302 M	321 M	336 M	351 M	363 M	274 M	274 M	274 M	274 M	-2.67 M	-2.67 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	57.6 M	83.3 M	107 M	130 M	155 M	185 M	211 M	235 M	262 M	281 M	302 M	321 M	336 M	351 M	363 M	274 M	274 M	274 M	274 M	-19.7 M	-19.7 M	-17.4 M	-	-14.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency